Inhibition of ATR Overcomes Chemotherapy Resistance in p53 Deficient Myeloma Cells

被引：2
|
作者：
Bouard, Louise [1 ,2 ]
Tessoulin, Benoit [1 ]
Descamps, Geraldine [3 ]
Touzeau, Cyrille [1 ]
Moreau, Philippe [4 ]
Amiot, Martine [3 ]
Pellat-Deceunynck, Catherine [3 ]
机构：
[1] Nantes Univ Hosp, Clin Hematol, Nantes, France
[2] CRCINA, Nantes, France
[3] Univ Nantes, CNRS, CRCINA, INSERM, Nantes, France
[4] Univ Hosp Hotel Dieu, Clin Hematol, Nantes, France
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-122547
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3109
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Inhibition of ATR overcomes the PARP inhibitor resistance of BRCA-deficient cancer cells
    Yazinski, A.
    Zou, Lee
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 17 - 17
  • [2] Combined inhibition of CTPS1 and ATR is a metabolic vulnerability in p53-deficient myeloma cells
    Durand, Romane
    Bellanger, Celine
    Descamps, Geraldine
    Dousset, Christelle
    Maiga, Sophie
    Derrien, Jennifer
    Thirouard, Laura
    Bouard, Louise
    Asnagli, Helene
    Beer, Philip
    Parker, Andrew
    Gomez-Bougie, Patricia
    Devilder, Marie-Claire
    Moreau, Philippe
    Touzeau, Cyrille
    Moreau-Aubry, Agnes
    Chiron, David
    Pellat-Deceunynck, Catherine
    HEMASPHERE, 2024, 8 (10):
  • [3] Inhibition of p62-ZZ Domain-Mediated Signaling Overcomes Bortezomib Resistance in Multiple Myeloma Cells Independent of Their p53 Status
    Marino, Silvia
    Petrusca, Daniela Nicoleta
    Silberman, Rebecca
    Toscani, Denise
    Anderson, Judith L.
    Giuliani, Nicola
    Xie, Xiang-Qun
    Kurihara, Noriyoshi
    Roodman, G. David
    BLOOD, 2017, 130
  • [4] Inhibition of PSF Activity Overcomes Resistance to Treatment in Cancers Harboring Mutant p53
    Takayama, Ken-ichi
    Sato, Tomohiro
    Honma, Teruki
    Yoshida, Minoru
    Inoue, Satoshi
    MOLECULAR CANCER THERAPEUTICS, 2025, 24 (03) : 370 - 383
  • [5] Decitabine and Melphalan Fail to Reactivate p73 in p53 Deficient Myeloma Cells
    Gillardin, Pierre-Samuel
    Descamps, Geraldine
    Maiga, Sophie
    Tessoulin, Benoit
    Djamai, Hanane
    Lucani, Benedetta
    Chiron, David
    Moreau, Philippe
    Le Gouill, Steven
    Amiot, Martine
    Pellat-Deceunynck, Catherine
    Moreau-Aubry, Agnes
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (01)
  • [6] Expression of p14ARF overcomes tumor resistance to p53
    Lu, WG
    Lin, JY
    Chen, JD
    CANCER RESEARCH, 2002, 62 (05) : 1305 - 1310
  • [7] Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy
    Blandino, G
    Levine, AJ
    Oren, M
    ONCOGENE, 1999, 18 (02) : 477 - 485
  • [8] Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy
    Giovanni Blandino
    Arnold J Levine
    Moshe Oren
    Oncogene, 1999, 18 : 477 - 485
  • [9] Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR
    Reaper P.M.
    Griffiths M.R.
    Long J.M.
    Charrier J.-D.
    MacCormick S.
    Charlton P.A.
    Golec J.M.C.
    Pollard J.R.
    Nature Chemical Biology, 2011, 7 (7) : 428 - 430
  • [10] Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR
    Reaper, Philip M.
    Griffiths, Matthew R.
    Long, Joanna M.
    Charrier, Jean-Damien
    MacCormick, Somhairle
    Charlton, Peter A.
    Golec, Julian M. C.
    Pollard, John R.
    NATURE CHEMICAL BIOLOGY, 2011, 7 (07) : 428 - 430
12345